These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 26854035)

  • 21. Artificial neural networks estimating survival probability after treatment of choroidal melanoma.
    Damato B; Eleuteri A; Fisher AC; Coupland SE; Taktak AF
    Ophthalmology; 2008 Sep; 115(9):1598-607. PubMed ID: 18342942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on the management of posterior uveal melanoma.
    Zhao DY; Shields CL; Shields JA; Gunduz K
    J Ophthalmic Nurs Technol; 1998; 17(2):66-71. PubMed ID: 9677975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local Recurrence Significantly Increases the Risk of Metastatic Uveal Melanoma.
    Ophthalmic Oncology Task Force
    Ophthalmology; 2016 Jan; 123(1):86-91. PubMed ID: 26505803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant interferon therapy for patients with uveal melanoma at high risk of metastasis.
    Lane AM; Egan KM; Harmon D; Holbrook A; Munzenrider JE; Gragoudas ES
    Ophthalmology; 2009 Nov; 116(11):2206-12. PubMed ID: 19744725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Late results in treating uveal melanomas. A comparative evaluation of enucleation and organ-preserving treatment methods].
    Libman ES; Brovkina AF; Bezrukov AV
    Oftalmol Zh; 1989; (6):336-8. PubMed ID: 2622596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uveal melanoma in Israel in the last two decades: characterization, treatment and prognosis.
    Frenkel S; Hendler K; Pe'er J
    Isr Med Assoc J; 2009 May; 11(5):280-5. PubMed ID: 19637505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of delayed treatment in growing posterior uveal melanomas.
    Augsburger JJ; Vrabec TR
    Arch Ophthalmol; 1993 Oct; 111(10):1382-6. PubMed ID: 8216019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Pediatric and Young Adult Choroidal and Ciliary Body Melanoma Genetic Study, A Survey by the European Ophthalmic Oncology Group.
    van Poppelen NM; Cassoux N; Turunen JA; Naus NC; Verdijk RM; Vaarwater J; Cohen V; Papastefanou VP; Kiratli H; Saakyan SV; Tsygankov AY; Rospond-Kubiak I; Mudhar HS; Salvi SM; Kiilgaard JF; Heegaard S; Moulin AP; Saornil MA; Garciá-Alvarez C; Fili M; Eide NA; Meyer P; Kivelä TT; de Klein A; Kilic E; Al-Jamal RT
    Invest Ophthalmol Vis Sci; 2024 Apr; 65(4):12. PubMed ID: 38573618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matched group study of surgical resection versus cobalt-60 plaque radiotherapy for primary choroidal or ciliary body melanoma.
    Augsburger JJ; Lauritzen K; Gamel JW; DeBrakeleer DJ; Lowry JC; Eisenman R
    Ophthalmic Surg; 1990 Oct; 21(10):682-8. PubMed ID: 2250849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proton therapy for uveal melanoma in 43 juvenile patients: long-term results.
    Petrovic A; Bergin C; Schalenbourg A; Goitein G; Zografos L
    Ophthalmology; 2014 Apr; 121(4):898-904. PubMed ID: 24405742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uveal melanoma and pregnancy. A report of 16 cases.
    Shields CL; Shields JA; Eagle RC; De Potter P; Menduke H
    Ophthalmology; 1991 Nov; 98(11):1667-73. PubMed ID: 1800927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant melanoma of the choroid and the ciliary body 1956-1975 in Halland and Gothenburg. Incidence, histopathology and prognosis.
    Abrahamsson M
    Acta Ophthalmol (Copenh); 1983 Aug; 61(4):600-10. PubMed ID: 6637421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. KI-67 immunopositivity in choroidal and ciliary body melanoma with respect to nucleolar diameter and other prognostic factors.
    Al-Jamal RT; Kivelä T
    Curr Eye Res; 2006 Jan; 31(1):57-67. PubMed ID: 16421020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No differences in the long-term prognosis of iris and choroidal melanomas when adjusting for tumor thickness and diameter.
    Sabazade S; Herrspiegel C; Gill V; Stålhammar G
    BMC Cancer; 2021 Nov; 21(1):1270. PubMed ID: 34819035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of uveal melanoma in Europe.
    Virgili G; Gatta G; Ciccolallo L; Capocaccia R; Biggeri A; Crocetti E; Lutz JM; Paci E;
    Ophthalmology; 2007 Dec; 114(12):2309-15. PubMed ID: 17498805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up.
    Yue H; Qian J; Yuan Y; Zhang R; Bi Y; Meng F; Xuan Y
    Curr Eye Res; 2017 May; 42(5):759-765. PubMed ID: 27911584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of prognostic covariates for uveal melanoma.
    Gamel JW; McCurdy JB; McLean IW
    Invest Ophthalmol Vis Sci; 1992 May; 33(6):1919-22. PubMed ID: 1582798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melanoma of the eye: revealing hidden secrets, one at a time.
    Shields CL; Kels JG; Shields JA
    Clin Dermatol; 2015; 33(2):183-96. PubMed ID: 25704938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transscleral resection versus iodine brachytherapy for choroidal malignant melanomas 6 millimeters or more in thickness: a matched case-control study.
    Kivelä T; Puusaari I; Damato B
    Ophthalmology; 2003 Nov; 110(11):2235-44. PubMed ID: 14597535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.